Natalie Baker
Psychiatry · Omaha, NENPI 1174564082
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,801 and has fallen 98.4% since, to $28 in 2023.
Across 226 payments — averaging $15.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$573
- Otsuka America Pharmaceutical, Inc.$371
- Lundbeck LLC$355
- Vanda Pharmaceuticals Inc.$284
- Alkermes, Inc.$230
- Johnson & Johnson$221
- plus $2K from 17 others
What the payments were for
- Food & beverage$3,48597%
- Education$933%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $573 |
| Otsuka America Pharmaceutical, Inc. | 22 | $371 |
| Lundbeck LLC | 23 | $355 |
| Vanda Pharmaceuticals Inc. | 14 | $284 |
| Alkermes, Inc. | 14 | $230 |
| Johnson & Johnson | 11 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $199 |
| Jazz Pharmaceuticals Inc. | 13 | $171 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $160 |
| Sunovion Pharmaceuticals Inc. | 8 | $133 |
| Avanir Pharmaceuticals, Inc. | 9 | $124 |
| Supernus Pharmaceuticals, Inc. | 5 | $107 |
| Teva Pharmaceuticals USA, Inc. | 3 | $101 |
| Neurocrine Biosciences, Inc. | 6 | $87 |
| Neos Therapeutics, LP | 5 | $76 |
| Ironshore Pharmaceuticals Inc. | 5 | $75 |
| Eisai Inc. | 5 | $70 |
| Adlon Therapeutics L.p. | 3 | $58 |
| Harmony Biosciences LLC | 4 | $57 |
| Arbor Pharmaceuticals, Inc. | 3 | $44 |
| Alfasigma USA, Inc. | 2 | $42 |
| Bausch Health US, LLC | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
How this compares
$3,577 in reported general payments places this provider in the 85th percentile of 160 psychiatry providers in Nebraska.
Other psychiatry in Omaha
- Vithyalakshmi SelvarajOmaha$1.2M
- Sarit HovavOmaha$307K
- Mary Jo HaniganOmaha$119K
- Yon ChongOmaha$59K
- Syed SattarOmaha$16K
- Michael SedlacekOmaha$15K
- Sriram RamaswamyOmaha$13K
- Elizabeth FitzpatrickOmaha$10K
- Praveen FernandesOmaha$5K
- Michael EggerOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.